Description

6-(o-Chlorophenyl)-4-Methyl-2-(2-Morpholinoethyl)-3(2H)-Pyridazinone Hydrochloride is a high-purity, non-racemic pharmaceutical intermediate and research chemical of significant synthetic interest. Its value lies in its role as a key building block for the development of novel therapeutic agents, particularly within the central nervous system (CNS) and cardiovascular research domains. This compound is essential for pharmaceutical R&D laboratories, advanced organic synthesis, and manufacturers of active pharmaceutical ingredients (APIs) seeking to develop new drug candidates.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug molecules, particularly those targeting neurological pathways.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and the discovery of new bioactive compounds.
• Chemical Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Organic Synthesis Building Block: Utilized in academic and industrial research for constructing complex heterocyclic systems containing pyridazinone and morpholine motifs.
• Preclinical Studies: Employed in the early-stage development of potential therapeutic agents for various disease models.

Basic Information

Product Name	6-(o-Chlorophenyl)-4-Methyl-2-(2-Morpholinoethyl)-3(2H)-Pyridazinone Hydrochloride
CAS No.	29242-40-8
Molecular Formula	C₁₇H₂₀ClN₃O₂·HCl
Molecular Weight	370.72 g/mol
Synonyms	6-(2-Chlorophenyl)-4-methyl-2-(2-morpholin-4-ylethyl)-2,3-dihydropyridazin-3-one hydrochloride; 2-(2-Morpholinoethyl)-6-(o-chlorophenyl)-4-methyl-3(2H)-pyridazinone hydrochloride; 6-(2-Chlorophenyl)-4-methyl-2-[2-(4-morpholinyl)ethyl]-3(2H)-pyridazinone monohydrochloride; 29242-40-8; 6-(o-Chlorophenyl)-4-methyl-2-(2-morpholinoethyl)-3(2H)-pyridazinone HCl; 3(2H)-Pyridazinone, 6-(2-chlorophenyl)-4-methyl-2-[2-(4-morpholinyl)ethyl]-, monohydrochloride
EINECS	Contact for details

Quality Control

Our 6-(o-Chlorophenyl)-4-Methyl-2-(2-Morpholinoethyl)-3(2H)-Pyridazinone Hydrochloride is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR, to ensure it meets the high standards required for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.